Korea vs Latvia: Pharmaceutical consumption
Pharmaceutical consumption over time
- Korea
- Latvia
How they compare
Korea currently reports 379.9 Defined daily dose per 1 000 inhabitants per day against 362.1 Defined daily dose per 1 000 inhabitants per day in Latvia, a difference of 17.8 Defined daily dose per 1 000 inhabitants per day.
The two have swapped places 2 times across 13 shared years of data; in 2012 it was Korea ahead.
Korea ranks 1st and Latvia ranks 2nd of 3 groups.
Across the 2 decades both report, Korea averaged higher in 1 and Latvia in 1.
Head to head by decade
| Decade | Korea | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 285.73 Defined daily dose per 1 000 inhabitants per day | 224.75 Defined daily dose per 1 000 inhabitants per day | 60.98 Defined daily dose per 1 000 inhabitants per day | Korea |
| 2020s | 351.44 Defined daily dose per 1 000 inhabitants per day | 379.18 Defined daily dose per 1 000 inhabitants per day | 27.74 Defined daily dose per 1 000 inhabitants per day | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pharmaceutical consumption, Korea or Latvia?
- Korea, at 379.9 Defined daily dose per 1 000 inhabitants per day against 362.1 Defined daily dose per 1 000 inhabitants per day in Latvia as of 2024.
- What is the difference in pharmaceutical consumption between Korea and Latvia?
- 17.8 Defined daily dose per 1 000 inhabitants per day, with Korea ahead.
- How many years of comparable data are there for Korea and Latvia?
- 13 years are reported by both, from 2012 to 2024.
- How do Korea and Latvia rank globally for pharmaceutical consumption?
- Korea ranks 1st and Latvia ranks 2nd of 3 groups.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Pharmaceutical consumption. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Total pharmaceutical consumption according to the Anatomical Therapeutic Chemical (ATC) classification/Defined Daily Dose (DDD) system, created by the WHO Collaborating Centre for Drug Statistics Methodology. The unit of measurement is Defined Daily Dose (DDD), defined as the assumed average maintenance dose per day for a drug used on its main indication in adults. The Anatomical Therapeutic Chemical classification system divides drugs into different groups according to the organ system on which they act and/or therapeutical, pharmacological and chemical characteristics. The main principles for the classification of medicinal substances according to the ATC is presented in the publication “Guidelines for ATC classification and DDD assignment”, WHO Collaborating Centre for Drug Statistics Methodology, Oslo. The publication “ATC Index with DDDs” lists all assigned ATC codes and DDD values. Both these publications are updated annually. The ATC codes are based on the 2026 version of the ATC Index. All alterations implemented from January 2026 are available on the WHO Collaborating Centre for Drug Statistics Methodology website at https://www.whocc.no/lists_of__temporary_atc_ddds_and_alterations/. Data should reflect, where possible, the total consumption for each pharmaceutical drug category, i.e. including consumption in hospitals. Please refer to the Sources and Methods for detailed country-specific information.